Investor presentation March 2024
Find out more ➝

Proteomics International signs agreement with University of Oxford to further validate 'PromarkerEndo' test for endometriosis
Find out more ➝

European patent granted for OxiDx technology
Find out more ➝

US Medicare confirms reimbursement price for PromarkerD
Find out more ➝

Proteomics’ new oesophageal cancer test presented at global conference
Find out more ➝
PromarkerD Analytical Services Diagnostics Investors

Newsroom

PIQ Announcements Blood test for kidney decline in Type 1 diabetes –... Read more ➝ Proteomics testing pinpoints future kidney disease risk... Read more ➝ The Silent Killer: Prevention is the next cure – ... Read more ➝
Subscribe

  • This field is for validation purposes and should be left unchanged.
Menu